What is Aimovig
Aimovig is a prescription medicine that helps prevent migraine in adults. It is indicated for patients who have at least four migraine days per month.
Aimovig is available as one injection, once a month, with the Aimovig pre-filled syringe or a pre-filled pen. It comes in two doses: 70 mg and 140 mg. The recommended dose is 70 mg every four weeks, but the dose may be increased 140 mg dose depending on the effectiveness of the lower dose.1
For some people, Aimovig can cut the number of monthly migraine days in half or more.2
In a three-month study, people with chronic migraine experienced 6-7 fewer monthly migraine days on average. Aimovig was also tested on patients with episodic migraine over a six-month period, with an average of 3-4 fewer migraine days per month.2
Aimovig should not be used by patients who are allergic or hypersensitive to the active substance, erenumab-aooe, or any of its ingredients.1
How does it work?
Aimovig is specifically designed to help prevent migraine. It works by selectively targeting and blocking the calcitonin gene-related peptide receptors (CGRP-R) in the body, which may play a key role in migraine, so that CGRP cannot attach to them. It is the first and only migraine preventive treatment that works in this way.2
Method of administration
Aimovig is for subcutaneous use. The injection is to be administered into the outer area of the upper arm by a suitably trained pharmacist. Injection sites should be rotated and injections should not be given into areas where the skin is tender, bruised, red or hard.1
Aimovig comes in either a pre-filled syringe or a pre-filled pen. They are for single use, and the entire contents should be injected. Prior to administration, the solution should be checked to ensure that it is clear to opalescent, colourless to
light yellow, and free from particles or flakes.1
The package leaflet contains comprehensive instructions for administration.
Following a consultation with our pharmacist we can review your current symptoms and history to see if this is suitable for you. No appointment is necessary and the service is available in all our pharmacies.
Please visit the EMC website for the Aimovig prescribing information.
Price: The cost for treatment following a consultation is £500 which covers a one month supply.
Frequency: When required…
- Novartis Pharmaceuticals UK Ltd, Summary of product characteristics, Aimovig 140 mg solution for injection in pre-filled pen, Updated 10 September 2019 [Accessed 04 November 2019], available at: https://www.medicines.org.uk/emc/product/10297/smpc
- Aimovig.com, what is Aimovig, Accessed 04 November 2019, available at: https://www.aimovig.com/what-is-aimovig
Select your preferred pharmacy to visit their page and enquire about this service or just pop in when it suits you.